CS logo
small CS logo
Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum

Munchen, Germany
Hospital department in Munich, Bavaria
Ismaninger Str. 22, 81675 München

About Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


During the past decade, Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111002222001100110000001100Started TrialsCompleted Trails20162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
2000-12-01
2003-01-01
Completed
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
2000-12-01
2003-01-01
Completed
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
2004-09-01
2007-01-01
Terminated
43
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
Modulating Pain Using Transcranial Alternating Stimulation (tACS) in Healthy Human Subjects
2019-04-15
2019-10-23
Completed
39
Sensory Evidence and Expectations in Pain Processing
2020-03-01
2020-12-01
Completed
50

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum" #1 collaborator was "German Research Foundation" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Studienstiftung des deutschen Volkes" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum" are "Experimental Pain in Healthy Human Subjects" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Acute Ischemic Stroke" (1 trials), "Cerebrovascular Accident" (1 trials) and "Experimental Pain in Healthy Human Participants" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


Most popular intervention types in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum" are "Drug" (6 trials), "Device" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (4 trials), "10 Hz tACS of the bilateral somatosensory cortex" (1 trials), "10 Hz tACS of the prefrontal cortex" (1 trials), "80 Hz tACS of the bilateral somatosensory cortex" (1 trials) and "80 Hz tACS of the prefrontal cortex" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


The vast majority of trials in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum" are 11 trials for "All" genders.

Clinical Trials Status at Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum


Currently, there are NaN active trials in "Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status